erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Takada T et al. [Study of specific mRNA expression by peripheral monocytes of patients with diffuse panbronchitis using cDNA representational difference analysis (RDA)]. 1997 Jpn J Antibiot pmid:9597465
Hoshina S et al. [C kinase activation and induction of HL 60 promyelocytic leukemia cell differentiation caused by roxithromycin]. 1997 Jpn J Antibiot pmid:9597464
Tei A et al. [Effects and actions of EM (erythromycin), CAM (clarithromycin), and JM (josamycin) on IL-4 and IL-5 production by monocytes]. 1997 Jpn J Antibiot pmid:9597458
Kudo S [Preliminary survey on DPB (diffuse panbronchitis) in Japan and a survey on the status of DPB in China]. 1997 Jpn J Antibiot pmid:9597457
Kondo K et al. [Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597456
Kobayashi O et al. [Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597455
Ohara K et al. [Effects of pretreatment by erythromycin or rokitamycin on aminoglycoside inactivating enzyme of Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597454
Sato K et al. [Pyocyanine synthesis by Pseudomonas aeruginosa in chronic airway infection and the effect of erythromycin on its biological activity]. 1997 Jpn J Antibiot pmid:9597453
Mineshita M et al. [Effect of macrolide antibiotics on actin polymerization reactions of neutrophils]. 1997 Jpn J Antibiot pmid:9597447
Kawasaki S et al. [Effects of a steroid and macrolide antibiotic on IL-8 production by neutrophils]. 1997 Jpn J Antibiot pmid:9597446
Suzuki H et al. [Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics]. 1997 Jpn J Antibiot pmid:9597442
Nakada J et al. [Effects of erythromycin and roxithromycin on airway goblet cell secretion]. 1997 Jpn J Antibiot pmid:9597441
Ieshiro R et al. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer]. 1997 Jpn J Antibiot pmid:9597440
Sakata K et al. [Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation]. 1997 Jpn J Antibiot pmid:9597435
Hoover J "Antibiotic selection for endodontic infections". 1995 J Gt Houst Dent Soc pmid:9594808
de Bethune MP and Nierhaus KH Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes. 1978 Eur. J. Biochem. pmid:95947
Dodhia H and Miller E Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. 1998 Epidemiol. Infect. pmid:9593483
Spangler SK et al. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. 1998 Antimicrob. Agents Chemother. pmid:9593160
Goldstein EJ et al. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. 1998 Antimicrob. Agents Chemother. pmid:9593139
Wieteska M [Legionnaires' diseases]. 1998 Pol. Merkur. Lekarski pmid:9591446
Boiron M et al. Erythromycin elicits opposite effects on antro-bulbar and duodenal motility: analysis in diabetics by cineradiography. 1997 Arch. Physiol. Biochem. pmid:9587651
Bertho G et al. Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modelling. Ribosome-bound conformation determined by TRNOE and formation of cytochrome P450-metabolite complex. 1998 Int. J. Biol. Macromol. pmid:9585888
Bouvier d'Yvoire MJ et al. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes. 1998 J. Antimicrob. Chemother. pmid:9579715
Malizia T et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. 1998 J. Antimicrob. Chemother. pmid:9579710
Brett M et al. The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis. 1998 J. Antimicrob. Chemother. pmid:9579709
Ednie LM et al. Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. 1998 J. Antimicrob. Chemother. pmid:9578166
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Hoppe JE Susceptibility testing of Bordetella pertussis. 1998 J. Clin. Microbiol. pmid:9574735
Higa F et al. Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila. 1998 J. Clin. Microbiol. pmid:9574712
Piccolomini R et al. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. 1997 Oral Microbiol. Immunol. pmid:9573812
Stephenson GA et al. Formation of isomorphic desolvates: creating a molecular vacuum. 1998 J Pharm Sci pmid:9572901
Griesgraber G et al. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572891
Elliott RL et al. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572890
Juanqin G et al. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. 1998 Mar-Apr Pediatr Dermatol pmid:9572705
Roark GA Guest clinician: an alternative treatment of RAU (recurrent apthous ulcers). 1996 Miss Dent Assoc J pmid:9571920
Andrews PA Interactions with ciprofloxacin and erythromycin leading to aminophylline toxicity. 1998 Nephrol. Dial. Transplant. pmid:9568870
Riley RJ and Howbrook D In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. 1997 J Pharmacol Toxicol Methods pmid:9566442
Delgado LF et al. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. 1998 Ann. Allergy Asthma Immunol. pmid:9564984
Jamkhedkar PP et al. Clinico-epidemiologic features of granuloma inguinale in the era of acquired immune deficiency syndrome. 1998 Sex Transm Dis pmid:9564722
Salah-Bey K et al. Targeted gene inactivation for the elucidation of deoxysugar biosynthesis in the erythromycin producer Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9563840
Kieran E et al. Group B streptococcus (GBS) colonisation among expectant Irish mothers. 1998 Jan-Feb Ir Med J pmid:9563251
Mitsuyama T et al. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. 1998 Mol. Cell. Biochem. pmid:9562252
Garcia-Bermejo I et al. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. 1998 Antimicrob. Agents Chemother. pmid:9559831
Hoppe JE and Bryskier A In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). 1998 Antimicrob. Agents Chemother. pmid:9559823
Roblin PM and Hammerschlag MR In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. 1998 Antimicrob. Agents Chemother. pmid:9559818
Barry AL et al. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). 1998 Antimicrob. Agents Chemother. pmid:9559816
Rutman A et al. Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. 1998 Antimicrob. Agents Chemother. pmid:9559781
Cleary RK et al. Metronidazole may inhibit intestinal colonization with Clostridium difficile. 1998 Dis. Colon Rectum pmid:9559631
Ross JI et al. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. 1998 Dermatology (Basel) pmid:9557230
Shah F Erythromycin. 1998 Pediatr Rev pmid:9557068